Canid offers an integrated platform that automates pediatric vaccine workflows by scanning a vaccine barcode and handling ordering, reporting, billing and compliance. The platform integrates directly with electronic health records and uses AI, software and economies of scale to remove administrative burden and financial risk from practices. Key features include automated logistics, guaranteed payments (no inventory risk), and data-driven patient outreach to improve vaccination completion rates. The company says its solution reduces the 15 weekly hours pediatricians spend on administrative tasks and frees clinicians to focus on patient care. Canid partners with more than 150 pediatricians across 12 states, covers over 300,000 children in patient panels, and has facilitated vaccinations for 121,000 patients. The recent funding will be used to expand the company’s reach among independent pediatric practices across the U.S. Canid provides an end-to-end vaccine workflow automation and management platform that helps practices manage the purchasing, delivery, and record management of vaccines. Its suite of tools offers practices a unified way to engage patients, close care gaps, and reduce provider burnout while delivering higher-quality care. The company’s platform is designed to empower clinicians and drive improvements in public health. Canid raised $1.5M in funding to support growth. The company intends to use the proceeds to expand its geographic presence to ten new U.S. states and to add new tools to manage vaccine patient populations.

Total raised

$12M

Funding rounds

2

Latest round

Series A

Latest activity

Jun 2025